| 1. |
World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec, 2009, 1263(1): 20-20.
|
| 2. |
Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut, 1996, 38(Suppl 2): S18-S23.
|
| 3. |
Kim HR, Cheon SH, Rha SY, et al. Treatment of recurrent hepatocellular carcinoma after liver transplantation. Liver Transplantation, 2011, 7(S2): 258-269.
|
| 4. |
Roayaie S, Schwartz JD, Sung MW, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl, 2004, 10(4): 534-540.
|
| 5. |
Llovet JM, Bruix J. Llovet JM, et al. Novel advancements in the management of hepatocel-lular carcinoma in 2008. J Hepatol 48 (Suppl 1): S20-S37.
|
| 6. |
劉清, 羅永勝, 王偉, 等. 凋亡素聯合阿霉素與順鉑對肝細胞癌的凋亡作用研究. 廣東醫學, 2009, 30(7): 1035-1037.
|
| 7. |
高廣猷. 抗癌新藥——順鉑簡介. 中國新藥與臨床雜志, 1983, 2(1): 23-27.
|
| 8. |
蒙志斌, 馬亦龍, 康平, 等. KMG 微球與碘油在選擇性支氣管動脈栓塞治療中晚期肺癌的療效分析. 廣西醫學, 2009, 31(7): 930-933.
|
| 9. |
張溪, 張博恒. 負載阿霉素的洗脫微球肝動脈化療栓塞治療難以手術切除的肝細胞肝癌的療效和安全性. 中國臨床醫學, 2013, 20(3): 419-421.
|